Antineoplastic agents travel the body and destroy cancer cells. Many of the side effects associated with antineoplastic agents occur because treatment destroys the body's normal cells in addition to cancerous cells. Alkylating agents for Cancer treatment, They generally have limited but important uses, and often have significant hepatotoxicity. The antineoplastic agents are not easily classified. Historically, they are categorized as (1) alkylating agents, (2) antimetabolites, (3) natural products, (4) hormones and antagonists, and (5) miscellaneous. In recent years, however, the miscellaneous group has come to include some of the most important agents. Anticancer agents can also be classified by indication (lymphoma, leukemia, melanoma, solid tumor), mechanism of action (such as alkylating agents, antibiotics, biological response modifiers, antiandrogens, topoisomerase inhibitors or protein kinase inhibitors), chemical structure (folic acid analog, platinum coordination complex, purine or pyrimidine analog, monoclonal antibody) or as cytotoxic or nonspecific vs noncytotoxic or targeted.
Related Journals: Cancer Medicine & Anti Cancer Drugs, Advances in Cancer Prevention, Chemotherapy, Cervical Cancer, Journal of Cancer Diagnosis, Journal of Cancer Clinical Trials, Apoptosis : an international journal on programmed cell death, Cancer Causes and Control, Stem Cell Reviews and Reports, Journal of Carcinogenesis, Oral Oncology, American Journal of Translational Research, Hormones and Cancer, Advances in Biological Regulation, Cancer genetics, Journal of Neuro-Oncology, Experimental Hematology.